The bigger companies wouldn’t even consider a small cap like Orthocell ASX 200 only.. Its a 200 - 300 grand bet, they will try and hold for a year in a hope for a small profit, maybe even double there monies, if you believe in management.
The prize has always been ATI partnership with Johnson & Johnson, we were hoping for news in the first 2 quarters, but with results to continue with Rotor cuff and Tennis elbow we just don’t know when this will end.
The other is Remplir, TGA approved and waiting on FDA, next move, always waiting, waiting
It’s a very typical Orthocell trading pattern, sell into the announcements and buy back in when it’s cheaper, it’s the only way to make money from this company.
OCC Trading, page-1183
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.5¢ |
Change
0.005(1.32%) |
Mkt cap ! $80.59M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 38.5¢ | 38.0¢ | $10.3K | 26.83K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3551 | 38.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 14559 | 1 |
View Market Depth
| Last trade - 13.46pm 16/05/2024 (20 minute delay) ? |
|
|||||
|
Last
38.5¢ |
Change
0.005 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 38.0¢ | 38.5¢ | 38.0¢ | 18729 | ||
| Last updated 13.46pm 16/05/2024 ? | |||||
| OCC (ASX) Chart |